Pfizer to 'catch our breath' on deals after $43B purchase
[ad_1] Pfizer CEO Albert Bourla said the pharma giant is pausing big acquisitions after spending $43 billion last year on buying Seagen Inc. “We need
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More
